Cerebral Amyloid Angiopathy Vascular Cells

Cerebral Amyloid Angiopathy Vascular Cells

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Cerebral Amyloid Angiopathy Vascular Cells</th>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0010012](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0010012)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0010012](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0010012)</td>
</tr>
</table>

Cerebral Amyloid Angiopathy Vascular Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Cerebral Amyloid Angiopathy Vascular Cells

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Cerebral Amyloid Angiopathy Vascular Cells</th>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0010012](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0010012)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0010012](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0010012)</td>
</tr>
</table>

Cerebral Amyloid Angiopathy Vascular Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

This page provides comprehensive information about the cell type. See the content below for detailed information. [@thal2008]

Cerebral amyloid angiopathy (CAA) involves amyloid-beta (Abeta) deposition in the walls of cerebral blood vessels. This primarily affects vascular smooth muscle cells (becoming called smooth muscle cells) and pericytes, leading to vessel fragility, hemorrhages, and impaired clearance. [@charidimou2017]

<!-- multi-taxonomy-enrichment -->

<!-- taxonomy-enrichment -->

Taxonomy & Classification

External Database Links

• [Cell Ontology (CL:0010012)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0010012)
• [OBO Foundry (CL:0010012)](http://purl.obolibrary.org/obo/CL_0010012)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: cerebral cortex neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

External Database Links

• [Cell Ontology (CL:0010012)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0010012)
• [OBO Foundry (CL:0010012)](http://purl.obolibrary.org/obo/CL_0010012)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Vascular Aβ Deposition

Aβ Peptides Involved

• Aβ40 - Most common in vessels
• Aβ42 - Less common, more aggregative
• Aβ43, Aβ44 - Rare variants

Vessels Affected

• Leptomeningeal arteries - Most severely
• Cortical arterioles - Common
• Capillaries - Variable involvement
• Veins - Rarely affected

Affected Cell Types

Vascular Smooth Muscle Cells

Changes:

• Amyloid replacement of media layer
• Smooth muscle cell loss
• Basement membrane thickening
• Vessel wall fragmentation

• Reduced vascular reactivity
• Increased vessel fragility
• Hemorrhagic risk
• Impaired Aβ clearance

Pericytes

Changes:

• Coverage reduction
• Morphological abnormalities
• Aβ accumulation
• Tight junction alterations

• BBB dysfunction
• Reduced capillary perfusion
• Enhanced Aβ transcytosis impairment
• Neurovascular coupling deficits

Endothelial Cells

Changes:

• Secondary dysfunction
• LRP1 downregulation
• RAGE upregulation
• NO production altered

• Impaired Aβ clearance
• Increased Aβ influx
• Inflammation activation

Clinical Manifestations

Symptoms

• Lobar hemorrhages - Cortical bleeds
• Cognitive decline - Vascular cognitive impairment
• Transient focal episodes - "Amyloid spells"
• White matter disease - Leukoaraiosis

Imaging Features

• MRI: Lobar microhemorrhages
• SWI: Cortical siderosis
• FLAIR: White matter hyperintensities
• PET: Amyloid binding

Association with Alzheimer's Disease

Overlap

• ~80% of AD patients have some CAA
• ApoE ε4 increases CAA risk
• Shared Aβ pathology
• Vascular contribution to dementia

Differences

• CAA: Vessels primarily affected
• AD: Parenchymal plaques dominant
• Different Aβ species
• Distinct clinical features

Therapeutic Strategies

Current Approaches

Emerging Treatments

• Aβ immunotherapy - May worsen CAA
• Vascular protective agents - Cerebrolysin
• ApoE targeting - Gene therapy
• Anti-angiogenic therapy - VEGF modulation

Background

The study of Cerebral Amyloid Angiopathy Vascular Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data